These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29076612)

  • 1. New Insights into SN-38 Glucuronidation: Evidence for the Important Role of UDP Glucuronosyltransferase 1A9.
    Xiao L; Zhu L; Li W; Li C; Cao Y; Ge G; Sun X
    Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):424-428. PubMed ID: 29076612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin.
    Hanioka N; Ozawa S; Jinno H; Ando M; Saito Y; Sawada J
    Xenobiotica; 2001 Oct; 31(10):687-99. PubMed ID: 11695848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.
    Rowland A; Knights KM; Mackenzie PI; Miners JO
    Drug Metab Dispos; 2008 Jun; 36(6):1056-62. PubMed ID: 18362158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms.
    Zhu L; Ge G; Zhang H; Liu H; He G; Liang S; Zhang Y; Fang Z; Dong P; Finel M; Yang L
    Drug Metab Dispos; 2012 Mar; 40(3):529-38. PubMed ID: 22180045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine serum albumin decreases Km values of human UDP-glucuronosyltransferases 1A9 and 2B7 and increases Vmax values of UGT1A9.
    Manevski N; Moreolo PS; Yli-Kauhaluoma J; Finel M
    Drug Metab Dispos; 2011 Nov; 39(11):2117-29. PubMed ID: 21856742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
    Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
    Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in-vitro glucuronidation of arctigenin.
    Xin H; Xia YL; Hou J; Wang P; He W; Yang L; Ge GB; Xu W
    J Pharm Pharmacol; 2015 Dec; 67(12):1673-81. PubMed ID: 26407805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.
    Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM
    Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human UDP-glucuronosyltransferase isoforms involved in haloperidol glucuronidation and quantitative estimation of their contribution.
    Kato Y; Nakajima M; Oda S; Fukami T; Yokoi T
    Drug Metab Dispos; 2012 Feb; 40(2):240-8. PubMed ID: 22028316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent and selective inhibition of magnolol on catalytic activities of UGT1A7 and 1A9.
    Zhu L; Ge G; Liu Y; He G; Liang S; Fang Z; Dong P; Cao Y; Yang L
    Xenobiotica; 2012 Oct; 42(10):1001-8. PubMed ID: 22591254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential rates of glucuronidation for 7-ethyl-10-hydroxy-camptothecin (SN-38) lactone and carboxylate in human and rat microsomes and recombinant UDP-glucuronosyltransferase isoforms.
    Tallman MN; Ritter JK; Smith PC
    Drug Metab Dispos; 2005 Jul; 33(7):977-83. PubMed ID: 15833930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical Kinetics and Albumin Effect of Glucuronidation of 5-n-Butyl-4-{4-[2-(1H-tetrazole-5- yl)-1H-pyrrol-1-yl]phenylmethyl}-2,4-dihydro-2-(2,6- dichlorophenyl)-3H-1,2,4-triazol-3-one, a Novel Nonpeptide Angiotensin Type 1 Receptor Antagonist, in Liver Microsomes and UDP-Glucuronosyl-transferase.
    Peng Y; Zhang X; Zhu Y; Wu H; Gu S; Chang Q; Zhou Y; Wang G; Sun J
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29562678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic UDP-glucuronosyltransferase is responsible for eslicarbazepine glucuronidation.
    Loureiro AI; Fernandes-Lopes C; Bonifácio MJ; Wright LC; Soares-da-Silva P
    Drug Metab Dispos; 2011 Sep; 39(9):1486-94. PubMed ID: 21673130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro characterisation of human renal and hepatic frusemide glucuronidation and identification of the UDP-glucuronosyltransferase enzymes involved in this pathway.
    Kerdpin O; Knights KM; Elliot DJ; Miners JO
    Biochem Pharmacol; 2008 Jul; 76(2):249-57. PubMed ID: 18541222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regio- and isoform-specific glucuronidation of psoralidin: evaluation of 3-o-glucuronidation as a functional marker for UGT1A9.
    Sun H; Ma Z; Lu D; Wu B
    J Pharm Sci; 2015 Jul; 104(7):2369-77. PubMed ID: 25941108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro glucuronidation of Armillarisin A: UDP-glucuronosyltransferase 1A9 acts as a major contributor and significant species differences.
    Sun D; Zhu L; Xiao L; Xia Y; Ge G; Cao Y; Wu Y; Yin J; Yang L
    Xenobiotica; 2014 Nov; 44(11):988-95. PubMed ID: 24916899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver.
    Girard H; Villeneuve L; Court MH; Fortier LC; Caron P; Hao Q; von Moltke LL; Greenblatt DJ; Guillemette C
    Drug Metab Dispos; 2006 Jul; 34(7):1220-8. PubMed ID: 16595709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ketoconazole on glucuronidation by UDP-glucuronosyltransferase enzymes.
    Yong WP; Ramirez J; Innocenti F; Ratain MJ
    Clin Cancer Res; 2005 Sep; 11(18):6699-704. PubMed ID: 16166450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The small-molecule tyrosine kinase inhibitor nilotinib is a potent noncompetitive inhibitor of the SN-38 glucuronidation by human UGT1A1.
    Fujita K; Sugiyama M; Akiyama Y; Ando Y; Sasaki Y
    Cancer Chemother Pharmacol; 2011 Jan; 67(1):237-41. PubMed ID: 20814789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.